Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Use of artificial intelligence in imaging dementia

Aljuhani, Manal, Ashraf, Azhaar and Edison, Paul 2024. Use of artificial intelligence in imaging dementia. Cells 13 (23) , 1965. 10.3390/cells13231965

[thumbnail of cells-13-01965.pdf] PDF - Published Version
Available under License Creative Commons Attribution.

Download (2MB)
License URL: https://creativecommons.org/licenses/by/4.0/
License Start date: 27 November 2024

Abstract

Alzheimer’s disease is the most common cause of dementia in the elderly population (aged 65 years and over), followed by vascular dementia, Lewy body dementia, and rare types of neurodegenerative diseases, including frontotemporal dementia. There is an unmet need to improve diagnosis and prognosis for patients with dementia, as cycles of misdiagnosis and diagnostic delays are challenging scenarios in neurodegenerative diseases. Neuroimaging is routinely used in clinical practice to support the diagnosis of neurodegenerative diseases. Clinical neuroimaging is amenable to errors owing to varying human judgement as the imaging data are complex and multidimensional. Artificial intelligence algorithms (machine learning and deep learning) enable automation of neuroimaging interpretation and may reduce potential bias and ameliorate clinical decision-making. Graph convolutional network-based frameworks implicitly provide multimodal sparse interpretability to support the detection of Alzheimer’s disease and its prodromal stage, mild cognitive impairment. In patients with amyloid-related imaging abnormalities, radiologists had significantly better detection performances with both ARIA-E (sensitivity higher in the assisted/deep learning method [87%] compared to unassisted [71%]) and for ARIA-H signs (sensitivity was higher in assisted [79%] compared to unassisted [69%]). A convolutional neural network method was developed, and external validation predicted final clinical diagnoses of Alzheimer’s disease, dementia with Lewy bodies, mild cognitive impairment due to Alzheimer’s disease, or cognitively normal with FDG-PET. The translation of artificial intelligence to clinical practice is plagued with technical, disease-related, and institutional challenges. The implementation of artificial intelligence methods in clinical practice has the potential to transform the diagnostic and treatment landscape and improve patient health and outcomes.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Additional Information: License information from Publisher: LICENSE 1: URL: https://creativecommons.org/licenses/by/4.0/, Start Date: 2024-11-27
Publisher: MDPI
ISSN: 2073-4409
Date of First Compliant Deposit: 6 December 2024
Date of Acceptance: 25 November 2024
Last Modified: 06 Dec 2024 09:46
URI: https://orca.cardiff.ac.uk/id/eprint/174541

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics